Long-term treatment with haloperidol decreases the mRNA levels of complexin I, but not complexin II, in rat prefrontal cortex, nucleus accumbens and ventral tegmental area

Neuroscience Letters

Volumn 290, Issue 1, 2000, Pages 29-32

  Nakahara, Tatsuo ^a   Motomura, Keisuke ^b   Hashimoto, Kijiro ^b   Ueki, Hiroshi ^b   Gotoh, Leo ^a   Hondo, Hisao ^b   Tsutsumi, Tetsuyuki ^b   Kuroki, Toshihide ^c   Hirano, Makoto ^b   Uchimura, Hideyuki ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b Hizen National Mental Hospital   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Complexin; Frontal cortex; Haloperidol; Nucleus accumbens; Synaptic protein; Ventral tegmental area

Indexed keywords

COMPLEXIN; COMPLEXIN I; COMPLEXIN II; HALOPERIDOL DECANOATE; MEMBRANE PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; LONG TERM EXPOSURE; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALS; BRAIN CHEMISTRY; HALOPERIDOL; MALE; NERVE TISSUE PROTEINS; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, WISTAR; RNA, MESSENGER; SUBSTANTIA NIGRA; VENTRAL TEGMENTAL AREA;

EID: 0034683222     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01312-4     Document Type: Article

References (19)

1. Eastwood S.L., Burnet P.W.J., Harrison P.J. Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain. Synapse. 36:2000;167-177.
2. Grace A.A., Bunney B.S., Moore H., Todd C.L. Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends Neurosci. 20:1997;31-37.
3. Harrison P.J., Eastwood S.L. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet. 352:1998;1669-1673.
4. Ishizuka T., Saisu H., Odani S., Abe T. Synaphin: a protein associated with the docking/fusion complex in presynaptic terminals. Biochem. Biophys. Res. Commun. 213:1995;1107-1114.
5. Itakura M., Misawa H., Sekiguchi M., Takahashi M. Transfection analysis of functional roles of complexin I and II in the exocytosis of two different types of secretory vesicles. Biochem. Biophys. Res. Commun. 265:1999;691-696.
6. McMahon H.T., Sudhof T.C. Synaptic core complex of synaptobrevin, syntaxin, and SNAP-25 forms high affinity α-SNAP binding site. J. Biol. Chem. 270:1995;2213-2217.
7. McMahon H.T., Missler M., Li C., Sudhof T.C. Complexins: cytosolic proteins that regulate SNAP receptor function. Cell. 83:1995;111-119.
8. Nakahara T., Kuroki T., Hashimoto K., Hondo H., Tsutsumi T., Motomura K., Ueki H., Hirano M., Uchimura H. Effect of atypical antipsychotics on phencyclidine-induced expression of arc in rat brain. NeuroReport. 11:2000;551-555.
9. Nakahara T., Nakamura K., Tsutsumi T., Hashimoto K., Hondo H., Hisatomi S., Motomura K., Uchimura H. Effect of chronic haloperidol treatment on synaptic protein mRNAs in the rat brain. Mol. Brain Res. 61:1998;238-242.
10. Nakahara T., Hirano M., Matsumoto T., Kuroki T., Tatebayashi Y., Tsutsumi T., Nishiyama K., Ooboshi H., Nakamura K., Yao H., Shiraishi A., Waki M., Uchimura H. Regional distribution of DNA and RNA in rat brain: a sensitive determination using high-performance liquid chromatography with electrochemical detection. Neurochem. Res. 15:1990;609-611.
11. Nudel U., Zakut R., Shani M., Neuman S., Levy Z., Yaffe D. The nucleotide sequence of the rat cytoplasmic β-actin gene. Nucl. Acids Res. 11:1983;1759-1771.
12. Oh-e Y., Miyazaki H., Matsunaga Y., Hashimoto M. Pharmacokinetics of haloperidol decanoate in rats. J. Pharmacobio.-Dyn. 14:1991;615-622.
13. Ono S., Baux G., Sekiguchi M., Fossier P., Morel N.F., Nihonmatsu I., Hirata K., Awaji T., Takahashi S., Takahashi M. Regulatory roles of complexins in neurotransmitter release from mature presynaptic nerve terminals. Eur. J. Neurosci. 10:1998;2143-2152.
14. Peters A., Palay S.L. The morphology of synapses. J. Neurocytol. 25:1996;687-700.
15. Sollner T., Whiteheart S.W., Brunner M., Erdjument-Bromage H., Geromanos S., Tempst P., Rothman J.E. SNAP receptors implicated in vesicle targeting and fusion. Nature. 362:1993;318-324.
16. Sollner T., Bennett M.K., Whiteheart S.W., Scheller R.H., Rothman J.E. A protein assembly-disassembly pathway in vitro may correspond to sequential steps of synaptic vesicle docking, activation, and fusion. Cell. 75:1993;409-418.
17. Sudhof T.C. The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature. 375:1995;645-653.
18. Takahashi S., Yamamoto H., Matsuda Z., Ogawa M., Yagyu K., Taniguchi T., Miyata T., Kaba H., Higuchi T., Okutani F., Fujimoto S. Identification of two highly homologous presynaptic proteins distinctly localized at the dendritic and somatic synapses. FEBS Lett. 368:1995;455-460.
19. Yamada M., Saisu H., Ishizuka T., Takahashi H., Abe T. Immunohistochemical distribution of the two isoforms of synaphin/complexin involved in neurotransmitter release: localization at the distinct central nervous system regions and synaptic types. Neuroscience. 93:1999;7-18.